Pharmaceutical Executive-07-02-2009

News Analysis
Pharmaceutical Executive

July 01, 2009

J&J emerged victorious in a patent suit claiming that the technology behind Abbott's blockbuster arthritis treatment Humira is too similar in design to J&J's Remicade. The cost to Abbott: $1.67 Billion.

Pharmaceutical Executive

July 01, 2009

A risk-based approach to records and information management can be an integral part of the effort to reduce costs stemming from litigation.